 | • レポートコード：MRC2Q12-19176 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、75ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、レファムリンのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 レファムリンのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 レファムリンの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 レファムリンのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのレファムリンの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のレファムリンの売上および2028年までの予測に焦点を当てています。 レファムリンのグローバル主要企業には、Nabriva、Sumitomo Pharma、Sinovant Sciencesなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 レファムリン市場は、タイプとアプリケーションによって区分されます。世界のレファムリン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 経口投与、注射 【アプリケーション別セグメント】 医療、科学研究 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - レファムリン製品概要 - タイプ別市場（経口投与、注射） - アプリケーション別市場（医療、科学研究） - 調査の目的 ・エグゼクティブサマリー - 世界のレファムリン販売量予測2017-2028 - 世界のレファムリン売上予測2017-2028 - レファムリンの地域別販売量 - レファムリンの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別レファムリン販売量 - 主要メーカー別レファムリン売上 - 主要メーカー別レファムリン価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（経口投与、注射） - レファムリンのタイプ別販売量 - レファムリンのタイプ別売上 - レファムリンのタイプ別価格 ・アプリケーション別市場規模（医療、科学研究） - レファムリンのアプリケーション別販売量 - レファムリンのアプリケーション別売上 - レファムリンのアプリケーション別価格 ・北米市場 - 北米のレファムリン市場規模（タイプ別、アプリケーション別） - 主要国別のレファムリン市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのレファムリン市場規模（タイプ別、アプリケーション別） - 主要国別のレファムリン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のレファムリン市場規模（タイプ別、アプリケーション別） - 主要国別のレファムリン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のレファムリン市場規模（タイプ別、アプリケーション別） - 主要国別のレファムリン市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのレファムリン市場規模（タイプ別、アプリケーション別） - 主要国別のレファムリン市場規模（トルコ、サウジアラビア） ・企業情報 Nabriva、Sumitomo Pharma、Sinovant Sciences ・産業チェーン及び販売チャネル分析 - レファムリンの産業チェーン分析 - レファムリンの原材料 - レファムリンの生産プロセス - レファムリンの販売及びマーケティング - レファムリンの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - レファムリンの産業動向 - レファムリンのマーケットドライバー - レファムリンの課題 - レファムリンの阻害要因 ・主な調査結果 |
It is an antibiotic medication used it to treat adults with community-acquired bacterial pneumonia.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Lefamulin is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Lefamulin is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Lefamulin is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Lefamulin include Nabriva, Sumitomo Pharma and Sinovant Sciences, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Lefamulin manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Lefamulin market. Further, it explains the major drivers and regional dynamics of the global Lefamulin market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Nabriva
Sumitomo Pharma
Sinovant Sciences
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by usage and by application segments based on sales, price, and value for the period 2017-2028.
Lefamulin Segment by Usage
Take Orally
Injection
Lefamulin Segment by Application
Medicine
Scientific Research
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Lefamulin market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Lefamulin, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Lefamulin, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Lefamulin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Lefamulin sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Lefamulin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Lefamulin sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Nabriva, Sumitomo Pharma and Sinovant Sciences, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Lefamulin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Lefamulin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by usage, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by usage, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by usage, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by usage, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by usage, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lefamulin sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Lefamulin Product Introduction
1.2 Market by Usage
1.2.1 Global Lefamulin Market Size Growth Rate by Usage, 2017 VS 2021 VS 2028
1.2.2 Take Orally
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Lefamulin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Medicine
1.3.3 Scientific Research
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Lefamulin Sales Estimates and Forecasts 2017-2028
2.2 Global Lefamulin Revenue Estimates and Forecasts 2017-2028
2.3 Global Lefamulin Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Lefamulin Sales by Region
2.4.1 Global Lefamulin Sales by Region (2017-2022)
2.4.2 Global Sales Lefamulin by Region (2023-2028)
2.5 Global Lefamulin Revenue by Region
2.5.1 Global Lefamulin Revenue by Region (2017-2022)
2.5.2 Global Lefamulin Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Lefamulin Sales by Manufacturers
3.1.1 Global Top Lefamulin Manufacturers by Sales (2017-2022)
3.1.2 Global Lefamulin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Lefamulin in 2021
3.2 Global Lefamulin Revenue by Manufacturers
3.2.1 Global Lefamulin Revenue by Manufacturers (2017-2022)
3.2.2 Global Lefamulin Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Lefamulin Revenue in 2021
3.3 Global Lefamulin Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Lefamulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Lefamulin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Usage
4.1 Global Lefamulin Sales by Usage
4.1.1 Global Lefamulin Historical Sales by Usage (2017-2022)
4.1.2 Global Lefamulin Forecasted Sales by Usage (2023-2028)
4.1.3 Global Lefamulin Sales Market Share by Usage (2017-2028)
4.2 Global Lefamulin Revenue by Usage
4.2.1 Global Lefamulin Historical Revenue by Usage (2017-2022)
4.2.2 Global Lefamulin Forecasted Revenue by Usage (2023-2028)
4.2.3 Global Lefamulin Revenue Market Share by Usage (2017-2028)
4.3 Global Lefamulin Price by Usage
4.3.1 Global Lefamulin Price by Usage (2017-2022)
4.3.2 Global Lefamulin Price Forecast by Usage (2023-2028)
5 Market Size by Application
5.1 Global Lefamulin Sales by Application
5.1.1 Global Lefamulin Historical Sales by Application (2017-2022)
5.1.2 Global Lefamulin Forecasted Sales by Application (2023-2028)
5.1.3 Global Lefamulin Sales Market Share by Application (2017-2028)
5.2 Global Lefamulin Revenue by Application
5.2.1 Global Lefamulin Historical Revenue by Application (2017-2022)
5.2.2 Global Lefamulin Forecasted Revenue by Application (2023-2028)
5.2.3 Global Lefamulin Revenue Market Share by Application (2017-2028)
5.3 Global Lefamulin Price by Application
5.3.1 Global Lefamulin Price by Application (2017-2022)
5.3.2 Global Lefamulin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Lefamulin Market Size by Usage
6.1.1 North America Lefamulin Sales by Usage (2017-2028)
6.1.2 North America Lefamulin Revenue by Usage (2017-2028)
6.2 North America Lefamulin Market Size by Application
6.2.1 North America Lefamulin Sales by Application (2017-2028)
6.2.2 North America Lefamulin Revenue by Application (2017-2028)
6.3 North America Lefamulin Market Size by Country
6.3.1 North America Lefamulin Sales by Country (2017-2028)
6.3.2 North America Lefamulin Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Lefamulin Market Size by Usage
7.1.1 Europe Lefamulin Sales by Usage (2017-2028)
7.1.2 Europe Lefamulin Revenue by Usage (2017-2028)
7.2 Europe Lefamulin Market Size by Application
7.2.1 Europe Lefamulin Sales by Application (2017-2028)
7.2.2 Europe Lefamulin Revenue by Application (2017-2028)
7.3 Europe Lefamulin Market Size by Country
7.3.1 Europe Lefamulin Sales by Country (2017-2028)
7.3.2 Europe Lefamulin Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Lefamulin Market Size by Usage
8.1.1 Asia Pacific Lefamulin Sales by Usage (2017-2028)
8.1.2 Asia Pacific Lefamulin Revenue by Usage (2017-2028)
8.2 Asia Pacific Lefamulin Market Size by Application
8.2.1 Asia Pacific Lefamulin Sales by Application (2017-2028)
8.2.2 Asia Pacific Lefamulin Revenue by Application (2017-2028)
8.3 Asia Pacific Lefamulin Market Size by Region
8.3.1 Asia Pacific Lefamulin Sales by Region (2017-2028)
8.3.2 Asia Pacific Lefamulin Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Lefamulin Market Size by Usage
9.1.1 Latin America Lefamulin Sales by Usage (2017-2028)
9.1.2 Latin America Lefamulin Revenue by Usage (2017-2028)
9.2 Latin America Lefamulin Market Size by Application
9.2.1 Latin America Lefamulin Sales by Application (2017-2028)
9.2.2 Latin America Lefamulin Revenue by Application (2017-2028)
9.3 Latin America Lefamulin Market Size by Country
9.3.1 Latin America Lefamulin Sales by Country (2017-2028)
9.3.2 Latin America Lefamulin Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Lefamulin Market Size by Usage
10.1.1 Middle East and Africa Lefamulin Sales by Usage (2017-2028)
10.1.2 Middle East and Africa Lefamulin Revenue by Usage (2017-2028)
10.2 Middle East and Africa Lefamulin Market Size by Application
10.2.1 Middle East and Africa Lefamulin Sales by Application (2017-2028)
10.2.2 Middle East and Africa Lefamulin Revenue by Application (2017-2028)
10.3 Middle East and Africa Lefamulin Market Size by Country
10.3.1 Middle East and Africa Lefamulin Sales by Country (2017-2028)
10.3.2 Middle East and Africa Lefamulin Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Nabriva
11.1.1 Nabriva Corporation Information
11.1.2 Nabriva Overview
11.1.3 Nabriva Lefamulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Nabriva Lefamulin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Nabriva Recent Developments
11.2 Sumitomo Pharma
11.2.1 Sumitomo Pharma Corporation Information
11.2.2 Sumitomo Pharma Overview
11.2.3 Sumitomo Pharma Lefamulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sumitomo Pharma Lefamulin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sumitomo Pharma Recent Developments
11.3 Sinovant Sciences
11.3.1 Sinovant Sciences Corporation Information
11.3.2 Sinovant Sciences Overview
11.3.3 Sinovant Sciences Lefamulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sinovant Sciences Lefamulin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sinovant Sciences Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Lefamulin Industry Chain Analysis
12.2 Lefamulin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Lefamulin Production Mode & Process
12.4 Lefamulin Sales and Marketing
12.4.1 Lefamulin Sales Channels
12.4.2 Lefamulin Distributors
12.5 Lefamulin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Lefamulin Industry Trends
13.2 Lefamulin Market Drivers
13.3 Lefamulin Market Challenges
13.4 Lefamulin Market Restraints
14 Key Findings in The Global Lefamulin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer